Compare
Arcosa, Inc. vs Valmont Industries Inc vs Proto Labs Inc
| Latest fiscal year | Arcosa, Inc. ACA | Valmont Industries Inc VMI | Proto Labs Inc PRLB |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-27 | 2025-12-31 |
| Revenue | $2.88B | $4.10B | $533.13M |
| Revenue growth (YoY) | +12.2% | +0.7% | +6.4% |
| Gross margin | 22.4% | 30.2% | 44.5% |
| Operating margin | 11.9% | 10.1% | 4.7% |
| Net margin | 7.2% | 8.6% | 4.0% |
| Net income | $208.40M | $353.69M | $21.24M |
| EPS (Diluted) | $4.24 | $16.79 | $0.88 |
| Operating cash flow | $341.10M | $456.48M | $74.50M |
| Free cash flow | $175.50M | $311.45M | $59.66M |
| Cash & equivalents | $214.60M | $187.14M | $110.83M |
| Total assets | $4.99B | $3.37B | $763.41M |
| Total liabilities | $2.34B | $1.73B | $89.48M |
| Shareholders' equity | $2.64B | $1.63B | $673.93M |
| Return on year-end equity | 7.9% | 21.7% | 3.2% |
| Shares outstanding | 49.00M | n/a | 23.63M |
Revenue, most recent five fiscal years
| Fiscal year | Arcosa, Inc. | Valmont Industries Inc | Proto Labs Inc |
|---|---|---|---|
| Latest | $2.88B Ended 2025-12-31 | $4.10B Ended 2025-12-27 | $533.13M Ended 2025-12-31 |
| 1 year earlier | $2.57B Ended 2024-12-31 | $4.08B Ended 2024-12-28 | $500.89M Ended 2024-12-31 |
| 2 years earlier | $2.31B Ended 2023-12-31 | $4.17B Ended 2023-12-30 | $503.88M Ended 2023-12-31 |
| 3 years earlier | $2.24B Ended 2022-12-31 | $4.35B Ended 2022-12-31 | $488.40M Ended 2022-12-31 |
| 4 years earlier | $2.04B Ended 2021-12-31 | $3.50B Ended 2021-12-25 | $488.10M Ended 2021-12-31 |